Associated Papers
Gene polymorphisms of ABC transporters are associated with clinical outcomes in children with acute lymphoblastic leukemia.
Zhai X et al.
Archives of Medical Science : Ams, 2012
Placental P-glycoprotein and breast cancer resistance protein: influence of polymorphisms on fetal drug exposure and physiology.
Hutson JR et al.
Placenta, 2010
ABCG2 Q141K polymorphism is associated with chemotherapy-induced diarrhea in patients with diffuse large B-cell lymphoma who received frontline rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone chemotherapy.
Kim IS et al.
Cancer Science, 2008
Pharmacogenetics influence treatment efficacy in childhood acute lymphoblastic leukemia.
Davidsen ML et al.
Journal of Pediatric Hematology/oncology, 2008
[Functional SNPs of the breast cancer resistance protein (ABCG2) gene altering the pharmacokinetics/pharmacodynamics of anticancer agents].
Sugimoto Y
Seikagaku. the Journal of Japanese Biochemical Society, 2005
Breast cancer resistance protein: molecular target for anticancer drug resistance and pharmacokinetics/pharmacodynamics.
Sugimoto Y et al.
Cancer Science, 2005
Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2.
Mizuarai S et al.
International Journal of Cancer, 2004
Genetic differences in Native Americans and tacrolimus dosing after kidney transplantation.
Chakkera HA et al.
Transplantation Proceedings, 0
Select a paper to view details